Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.
ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...
This story was originally published on CFO.com. To receive daily news and insights, subscribe to our free daily CFO.com newsletter. Retail’s latest wave of store closures is pushing finance teams to ...
Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...
FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading ...
The transaction materially strengthens Aclarion’s balance sheet, preserves capital structure integrity, and significantly extends the Company’s operating runway well past targeted near and medium-term ...
YouTube on MSN
55-year-old bank account balance: $0.38
Protect your Most Important Assets: Your Personal Information. GET your 14-Day FREE TRIAL following my link with AURA at NEW!
CalciMedica ( (CALC) ) has shared an announcement.
PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven cancers, today announced the closing of a Series B extension, bringing the ...
Former intelligence official Egisto Ott goes on trial in Vienna on Thursday, accused of spying for Russia in what is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results